Arvinas' Series A Round

Arvinas raised a round of funding on September 26, 2013.

Arvinas is a pharmaceutical company focused on developing new small molecules aimed at degrading disease-causing cellular proteins. The company is translating these protein degradation approaches into…

Articles about Arvinas' Series A Round: